COVID-19 Recovery Program Could Be Modeled After Virtual Sepsis Care
An existing virtual transition and recovery program for patients with sepsis may be used as a model for similar programs for COVID-19 survivors.
Sepsis
Sepsis
Latest News
Machine Learning Estimates Treatment Effect of Corticosteroids in Septic Shock
The researchers’ objective was to determine whether machine learning-derived estimated individual corticosteroid therapy effect yields better results than treat all or treat no one strategies in adult patients with septic shock.
Mechanically Ventilated Adults With Sepsis: Dexmedetomidine vs Propofol for Sedation
Light sedation with dexmedetomidine does not lead to more days alive without acute brain dysfunction compared with propofol in mechanically ventilated adults with sepsis.
Previous Infection and Antibiotic Use Linked to Guillain-Barré Syndrome
Danish researchers looked into whether hospital-diagnosed and community-treated infections are important risk factors for GBS by examining the magnitude and duration of associated GBS risk.
Outcome Disparities in Pediatric Sepsis By Ethnicity, Insurance Status
Study authors sought to determine whether hospital outcomes in childhood severe sepsis were influenced by race, ethnicity, or insurance status, which are proxies for socioeconomic positions.
Healthy Microbiome Is Key to Sepsis Management
The authors emphasize that sepsis treatment should be guided by the connection between the microbiota and sepsis outcomes.
Dexmedetomidine No Better Than Propofol for Adults With Sepsis
For light sedation of mechanically ventilated adults with sepsis, outcomes do not differ significantly for those receiving dexmedetomidine or propofol.
What Infectious Conditions Are Associated With Splenic Infarction?
This retrospective study aims to shed light on the relationship between splenic infarction and infection.
Optical Biosensor Predicts Sepsis or Severe Infection in Patients at Risk
A study examines the accuracy of a new optical biosensor point-of-care device for the detection of severe infections.
Disparities Seen in Pediatric Sepsis Outcomes in the U.S.
For children with severe sepsis outcomes vary by race or ethnicity and by insurance status.
Secondary Bloodstream Infections in COVID-19 Patients
Investigators reported detailed microbiology, risk factors, and outcomes of secondary bloodstream infections in patients with severe COVID-19.
Infectious Diseases Consultation Effectively Reduces Antibiotic Use in Hospitals
Investigators assessed whether a daily service of infectious disease consultation was more effective than weekly consultation to reduce antibiotic use without worsening clinical outcomes.
Predictors for Mixed C albicans Bacterial Bloodstream Infections During Hospitalization
Study authors explored the clinical features and outcomes of mixed Candida albicans/bacterial bloodstream infections compared with monomicrobial Candida albicans bloodstream infections in adult patients.
Risk Factors for Cytomegalovirus Reactivation in Patients With Sepsis
Investigators studied the reactivation of cytomegalovirus in critically ill patients with sepsis and identified measured of CMV reactivation that were associated with worse clinical outcomes.
MERINO Trial, Post-Hoc Analysis: Relationship Between MIC and 30-Day Mortality
Study authors assessed the association of piperacillin/tazobactam MIC, meropenem MIC, and beta-lactam resistance genes with mortality in the MERINO trial.
Beta-Blockers for Heart Rate Control in Sepsis-Associated Atrial Fibrillation
Treatment with beta-blockers vs amiodarone, calcium channel blockers, or digoxin was associated with improved heart control at 1, but not 6 hours in patients with sepsis and atrial fibrillation.
CREDIBLE-CR: Cefiderocol Effective for Serious Carbapenem-Resistant Gram-Negative Infections
Study authors assessed the efficacy and safety of cefiderocol vs best available therapy in adults with serious carbapenem-resistant Gram-negative infections.
Predictors of Acute Kidney Injury With Vancomycin OPAT
The incidence of acute kidney injury in patients treated with vancomycin outpatient parenteral antimicrobial therapy was assessed, and risk factors for AKI in this population were identified.
Addition of Ticagrelor to Antibiotics Clears MSSA Bacteremia: A Case Study
The effect of ticagrelor in addition to cefazolin plus ertapenem for the clearance of S aureus bacteremia was assessed in a case study.
Cefazolin and Ertapenem Salvage Therapy Rapidly Clears MSSA Bacteremia
Ertapenem and cefazolin combination therapy was studied to assess use as salvage therapy for persistent bacteremia against a MSSA blood-stream isolate.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
